Publications by authors named "Deborah Finco-Kent"

Claim this Profile
S
Synthesis and characterization of rhenium and technetium-99m labeled insulin.
Chitra Sundararajan, Travis R Besanger, Renee Labiris, Katharina J Guenther, Thomas Strack, Deborah Finco-Kent

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.
Gopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, Yu Chen Barrett, Ronald Bowsher, Deborah Finco-Kent

J Pharm Biomed Anal· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products.
Eugen Koren, Holly W Smith, Elizabeth Shores, Gopi Shankar, Deborah Finco-Kent

J Immunol Methods· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of a flow cytometric method for immunophenotyping peripheral blood lymphocytes from cynomolgus monkeys (Macaca fascicularis).
Deanna L Baker, Deborah L Finco-Kent, William J Reagan, Maryrose J Conklyn, Thomas T Kawabata

Vet Clin Pathol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological responses to exogenous insulin.
S Edwin Fineberg, Thomas T Kawabata, Deborah Finco-Kent, Robert J Fountaine, Gregory L Finch

Endocr Rev· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893.
Daniel J Baltrukonis, Deborah Finco-Kent, Thomas T Kawabata, Martin Poirier, Lynne Lesauteur

J Immunotoxicol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation.
Deborah Finco-Kent, Thomas T Kawabata

J Immunotoxicol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.
Tim Heise, Susanne Bott, Corinna Tusek, Jens-Armin Stephan, Tom Kawabata, Deborah Finco-Kent

Diabetes Care· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
S Edwin Fineberg, Tom Kawabata, Deborah Finco-Kent, Cameron Liu, Alan Krasner

J Clin Endocrinol Metab· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of radioligand binding assays to measure total, IgA, IgE, IgG, and IgM insulin antibodies in human serum.
MichaeI Moxness, Jim Foley, Mark Stene, Deborah Finco-Kent, Vahe Bedian

Ann N Y Acad Sci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Paul S Changelian, Mark E Flanagan, Douglas J Ball, Craig R Kent, Kelly S Magnuson, Deborah Finco-Kent

Science· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis